3-ft has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, S; Marunaka, T; Yamawaki, I; Yasumoto, M | 1 |
| Emi, Y; Kohnoe, S; Maehara, Y; Sugimachi, K; Takahashi, I; Yoshida, M | 1 |
2 other study(ies) available for 3-ft and Sarcoma 180
| Article | Year |
|---|---|
Studies on antitumor agents, 2. Syntheses and antitumor activities of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Fluorouracil; Lethal Dose 50; Mice; Neoplasms, Experimental; Rats; Sarcoma 180; Sarcoma, Yoshida; Tegafur | 1978 |
Hyperthermia enhances the inhibition of tumor growth by 1-(2-tetrahydrofuryl)-5-fluorouracil/uracil (1:4) in tumors in mice and humans.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Humans; Hyperthermia, Induced; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Phosphorylation; Sarcoma 180; Tegafur; Tumor Cells, Cultured | 1992 |